Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Common Stock | Options Exercise | $267K | +9.75K | +102.91% | $27.34 | 19.2K | Feb 23, 2024 | Direct | F1 |
transaction | PFE | Common Stock | Tax liability | -$12.5K | -451 | -2.35% | $27.76 | 18.8K | Feb 23, 2024 | Direct | F2 |
transaction | PFE | Common Stock | Tax liability | -$21.5K | -774 | -4.12% | $27.76 | 18K | Feb 23, 2024 | Direct | F3 |
transaction | PFE | Common Stock | Tax liability | -$216K | -7.88K | -43.78% | $27.37 | 10.1K | Feb 23, 2024 | Direct | F4, F5 |
transaction | PFE | Common Stock | Tax liability | -$9.83K | -354 | -3.5% | $27.76 | 9.77K | Feb 24, 2024 | Direct | F2, F6 |
transaction | PFE | Common Stock | Tax liability | -$38.5K | -1.39K | -14.19% | $27.76 | 8.38K | Feb 25, 2024 | Direct | F2, F6 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Stock Appreciation Rights | Options Exercise | $0 | -9.75K | -100% | $0.00* | 0 | Feb 23, 2024 | Common Stock | 9.75K | $27.34 | Direct |
Id | Content |
---|---|
F1 | The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
F2 | The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). |
F3 | The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. |
F4 | The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). |
F5 | Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |
F6 | Price is the closing price of Pfizer common stock on February 23, 2024. |